Asset Dedication’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$455 Buy
+2
New +$436 ﹤0.01% 1119
2025
Q3
– Sell
-5
Closed -$1.29K – 1224
2025
Q2
$1.29K Hold
5
– – ﹤0.01% 1064
2025
Q1
$1.12K Buy
+5
New +$1.17K ﹤0.01% 1011
2023
Q3
– Sell
-2
Closed – – 1049
2023
Q2
$0 Hold
2
– – ﹤0.01% 1025
2023
Q1
$0 Hold
2
– – ﹤0.01% 1053
2022
Q4
$0 Buy
+2
New +$439 ﹤0.01% 1111
2021
Q3
– Sell
-175
Closed -$43K – 1022
2021
Q2
$43K Hold
175
– – 0.01% 426
2021
Q1
$34K Hold
175
– – 0.01% 377
2020
Q4
$37K Hold
175
– – 0.01% 397
2020
Q3
$30K Hold
175
– – 0.01% 389
2020
Q2
$34K Hold
175
– – 0.01% 346
2020
Q1
$26K Hold
175
– – 0.01% 370
2019
Q4
$27K Hold
175
– – 0.01% 367
2019
Q3
$24K Hold
175
– – 0.01% 368
2019
Q2
$21K Hold
175
– – 0.01% 370
2019
Q1
$18K Hold
175
– – 0.01% 393
2018
Q4
$20K Hold
175
– – 0.01% 362
2018
Q3
$20K Buy
+175
New +$19.2K 0.01% 364

Other funds holding RMD

Asset Dedication's RMD Position: Q3 2026 in Review

Asset Dedication opened a new position in ResMed (RMD) in Q3 2026: 2 shares worth $455. The stake represents ﹤0.01% of the portfolio and ranks #1119 among its holdings. This is a return to the name: Asset Dedication previously reported a position in RMD as recently as Q2 2025.

Asset Dedication first reported a position in RMD in Q3 2018 and has held it in 18 quarters since. The position peaked at $43K in Q2 2021. 741 funds tracked by Wall St. Rank hold RMD as of Q3 2026.

  • Asset Dedication held 2 shares of ResMed worth $455 as of Q3 2026.
  • ResMed was a new Asset Dedication position in Q3 2026.
  • ResMed made up ﹤0.01% of Asset Dedication's portfolio in Q3 2026, its #1119 holding.
  • Asset Dedication first reported a position in ResMed in Q3 2018 and has held it in 18 quarters since.
  • Asset Dedication's ResMed position peaked at $43K in Q2 2021.
  • 741 funds tracked by Wall St. Rank held ResMed as of Q3 2026.

Based on Asset Dedication's 13F filing for Q3 2026, filed 3 Nov 2026.